Headed by Guilhem Richard, Goodwin's ECM practice is a go-to for clients active in the biotechnology sector, and its portfolio also includes agents, banks, and issuers. The team advises clients on significant transactions, from private placements and rights offerings, to IPOs. Its ability to combine forces with the firm's US offices is also another strong asset for the Parisian team, which regularly advises on cross-border transactions. Mariléna Gryparis provides further key support.
Legal 500 Editorial commentary
Testimonials
Collated independently by Legal 500 research team.
- ‘An extremely competent team, very responsive and available, and very friendly.’
- ‘A team with excellent knowledge in the field of biotechnology. Pragmatic and technically skilled, with excellent teamwork.'
- 'Guilhem Richard is an excellent lawyer.’
- ‘It is a very solid and responsive team, with a deep knowledge of cross-border (France-US) and complex transactions.’
- ‘Guilhem Richard and Mariléna Gryparis are two very notable members of the team. Very rigorous, creative, and friendly.’
Key clients
- Jefferies
- Evercore
- Stifel
- Bank Degroof Petercam SA/NV
- Invest Securities
- Leerink Partners
- BNP Paribas
- Phaxiam Therapeutics
- Van Lanschot Kempen
- Guggenheim
- B. Riley Securities
- Northland Capital Markets
Work highlights
Advised Jefferies, Evercore, and Stifel on the capital increase of Medincell for a total gross amount of €43m.
Advised Northland Capital Markets and B. Riley Securities, who acted as joint lead placement agents, and Yorkville Securities, who acted as a placement agent, on the $376m debt and equity offering of Sequans Communications S.A.
Advised Genfit on its royalty monetisation financing with HCRx for a total amount of €185m.
Lawyers
Next Generation Partners
Junior partners with significant recognition from clients and peers in the market and key roles on multiple matters.
Practice head
Guilhem Richard
Other key lawyers
Mariléna Gryparis